NCT07169604

Brief Summary

we will retrospectively investigate the effect of intratecal morphine administration on postoperative pain relief for patients scheduled for robotic hysterectomy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 12, 2025

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

3.9 years

First QC Date

August 19, 2025

Last Update Submit

September 9, 2025

Conditions

Pain Management

Outcome Measures

Primary Outcomes (1)

  • pain scores

    we will registered the visual analogue scale number

    admission at PACU admission, discharge from PACU, 24 hours after surgery (T2)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with gynaecological malignant or benign condition needed for hysterectomy

You may qualify if:

  • patients scheduled for robotic hysterectomy acceptation of written informed consent

You may not qualify if:

  • were contraindications to neuraxial anesthesia (such as coagulopathies, platelet count below 100,000/mm³ or thrombocytopathy), severe valvular heart disease, left ventricular ejection fraction less than 35%, history of obstructive or restrictive pulmonary disease, or significant neurological disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Policlinico Gemelli

Roma, RM, 00166, Italy

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

August 19, 2025

First Posted

September 12, 2025

Study Start

January 1, 2021

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 12, 2025

Record last verified: 2025-09

Locations

IT(1)